P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
Main Authors: | I. Aurer, S. Basic-Kinda, A. Grubesic, O. Jaksic, S. Mrdenovic, S. Novakovic-Coha, D. Lozic, M. Mikulic-Pisk, R. Serventi-Seiwerth, D. Dujmovic, A. Ostojic, B. Dreta, G. Pavlisa, M. Narancic, I. Hude-Dragicevic, T. Valkovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000849128.90079.53 |
Similar Items
-
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
by: Igor Aurer, et al.
Published: (2024-01-01) -
Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
by: Branimir Jakšić, et al.
Published: (2018-01-01) -
Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem
by: Zrinka Sertić, et al.
Published: (2022-11-01) -
P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
by: D. Galusic, et al.
Published: (2022-06-01) -
Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
by: Davor Galusic, et al.
Published: (2022-12-01)